Study shows that Libtayo plus chemotherapy has lower cost and a larger effect on improving quality-adjusted life years than ...

With the introduction of the Health Equity Index (HEI) to Star Ratings methodology, health plans have yet another incentive ...

Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis ...

Two groundbreaking studies shed light on combat’s lasting physical and psychological damage more than 50 years on.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim ...

The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...

Although their diagnosis about what ails U.S. healthcare and their prescription for remedying it are almost entirely from ...

The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and ...

Pemphigus is a rare autoimmune disease that causes painful blisters on the skin and mucous membranes, including the mouth, ...

Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...

The respiratory tract’s microbial microflora plays a significant role in determining the severity of RSV infections and the ...